Stemgent Obtains $6,297,998 New Round
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=fdad1ba9-cbad-435a-84d0-92d69df828de&Preview=1 - Date
2/1/2012 - Company Name
Stemgent - Mailing Address
One Kendall Square B6201 Cambridge, MA 02139 - Company Description
Stemgent advances stem cell science by providing proprietary reagents and tools developed and proven for reproducibility by some of the world’s leading stem cell scientists. - Website
http://www.stemgent.com - Transaction Type
Venture Equity - Transaction Amount
$6,297,998 - Transaction Round
Undisclosed - Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing. - M&A Terms
- Venture Investor
Undisclosed
